BofA Securities Upgrades Apellis Pharmaceuticals (APLS) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

December 4, 2023 4:38 PM EST
Get Alerts APLS Hot Sheet
Price: $41.03 --0%

Rating Summary:
    6 Buy, 23 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

BofA Securities analyst Tazeen Ahmad upgraded Apellis Pharmaceuticals (NASDAQ: APLS) from Neutral to Buy with a price target of $85.00 (from $52.00).


For an analyst ratings summary and ratings history on Apellis Pharmaceuticals click here. For more ratings news on Apellis Pharmaceuticals click here.


Shares of Apellis Pharmaceuticals closed at $61.58 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades